US FDA 2020 Novel Approval Count Rises To 53 At CDER, Plus 5 New CBER Biologics
Executive Summary
FDA reviewers stuck to established assessment practices during the coronavirus crisis and produced one of the agency’s largest yearly novel approval counts ever.